Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5336)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 26, 2021 (publication date) through Jul 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nashawi M, Ahmed MS, Amin T, Abualfoul M, Chilton R. Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy. World J Cardiol 2021; 13(12): 676-694 [PMID: 35070111 DOI: 10.4330/wjc.v13.i12.676] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v13/i12/676.htm |
| Number | Citing Articles |
| 1 |
Tadesse M. Abegaz, Ahmead Baljoon, Oluwaseun Kilanko, Fatimah Sherbeny, Askal Ayalew Ali. Machine learning algorithms to predict major adverse cardiovascular events in patients with diabetes. Computers in Biology and Medicine 2023; 164: 107289 doi: 10.1016/j.compbiomed.2023.107289
|
| 2 |
Lucia Scisciola, Vittoria Cataldo, Fatemeh Taktaz, Rosaria Anna Fontanella, Ada Pesapane, Puja Ghosh, Martina Franzese, Armando Puocci, Antonella De Angelis, Liberata Sportiello, Raffaele Marfella, Michelangela Barbieri. Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.1008922
|